Medline ® Abstract for Reference 72
of 'Treatment of male sexual dysfunction'
PDE5 inhibitor promotes melanin synthesis through the PKG pathway in B16 melanoma cells.
Zhang X, Yan G, Ji J, Wu J, Sun X, Shen J, Jiang H, Wang H
J Cell Biochem. 2012 Aug;113(8):2738-43.
PDE inhibitors could increase cellular cGMP levels and are used to treat erectile dysfunction as well as pulmonary arterial hypertension. cGMP production was reported to be necessary for UVB-induced melanin synthesis, however, the effect of PDE5 inhibitor on melanin synthesis has not been examined. We found that PDE5 inhibitor (sildenafil or vardenafil) and the cGMP analog 8-CPT-cGMP stimulated CREB phosphorylation, leading to increased tyrosinase expression and melanin synthesis, which was counteracted by KT5823, a selective cGMP-dependent protein kinase (PKG) inhibitor. However, KT5823 did not affect cAMP-elevating agent-mediated melanin synthesis, indicating that KT5823 selectively inhibited cGMP-induced melanin synthesis. This is the first study to find that PDE5 inhibitor can promote melanin synthesis and reveal that PKG-dependent CREB phosphorylation and tyrosinase expression is involved in cGMP-induced melanin synthesis. Our results suggest that PDE5 inhibitor may be beneficial for the treatment of hypopigmentation diseases.
Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China.